1. The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
During the past decade, several important clinical trials have provided evidence supporting a paradigm shift from surgical aortic valve replacement (SAVR) towards transcatheter aortic valve implantation (TAVI) for the treatment of patients with symptomatic severe aortic valve stenosis (AS). Randomised controlled trials (RCTs) are the cornerstone of evidence-based medicine and have been the major driver of this paradigm shift. However, other study types such as international multicentre registries (both prospective and retrospective), post-market real-world surveillance studies, and head-to-head comparisons of different types of transcatheter heart valve (THV) are also needed in order to strengthen this evidence and provide insights ...
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next articleDo we need alternative access in TAVR anymore?